This infection risk map indicating the vulnerability of different types of cancer to COVID‐19 infection, high ACE2 expression levels leading to higher risk of COVID‐19 infection and poorer prognosis of breast cancer, while better prognosis in ovarian cancer patients. This evidence concerns the gene ACE2 and ovarian carcinoma.